Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ECHO, ACBI, HRC, FLXN; Shareholders are Encouraged to Contact the Firm AccessWire - Thu Nov 4, 2021

NEW YORK, NY / ACCESSWIRE / November 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Echo Global Logistics, Inc. (NASDAQ:ECHO) concerning...

ECHO : 48.24 (+0.04%)
ACBI : 32.34 (-0.09%)
HRC : 155.96 (+0.03%)
FLXN : 9.12 (-0.22%)
Pacira's (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark Zacks - Wed Nov 3, 2021

Pacira's (PCRX) earnings beat estimates in the third quarter of 2021 while revenues miss the same. Its flagship product Exparel's sales rise year over year.

ENDP : 0.4650 (-19.52%)
PCRX : 63.59 (+0.87%)
ENTA : 41.87 (-4.86%)
FLXN : 9.12 (-0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FTSI, UMPQ, FLXN, ADMS; Shareholders are Encouraged to Contact the Firm PR Newswire - Thu Oct 28, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: FTS International, Inc. (NYSE:...

UMPQ : 16.91 (+1.50%)
FLXN : 9.12 (-0.22%)
ADMS : 8.22 (+0.74%)
FTSI : 26.49 (-0.15%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations PR Newswire - Tue Oct 26, 2021

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
AZPN : 194.01 (+3.75%)
EBMT : 19.45 (-0.92%)
Flexion (FLXN) to Report Q3 Earnings: What's in the Cards? Zacks - Mon Oct 25, 2021

On Flexion's (FLXN) third-quarter earnings call, investor focus will be on its updates on earnings and revenues and the upcoming merger with Pacira whereby the latter will acquire the former.

PCRX : 63.59 (+0.87%)
FLXN : 9.12 (-0.22%)
ARDX : 0.6532 (-3.23%)
GMTX : 1.3500 (-5.59%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FLXN, AZPN, COLB, LMRK; Shareholders are Encouraged to Contact the Firm PR Newswire - Wed Oct 20, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Flexion Therapeutics, Inc. (NASDAQ:...

FLXN : 9.12 (-0.22%)
AZPN : 194.01 (+3.75%)
COLB : 28.78 (+1.70%)
LMRK : 16.49 (+0.30%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its Ongoing Investigations PR Newswire - Mon Oct 18, 2021

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
AZPN : 194.01 (+3.75%)
EBMT : 19.45 (-0.92%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, ACBI, SQ; Shareholders are Encouraged to Contact the Firm PR Newswire - Fri Oct 15, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Adamas Pharmaceuticals, Inc....

ADMS : 8.22 (+0.74%)
FLXN : 9.12 (-0.22%)
ACBI : 32.34 (-0.09%)
SQ : 83.44 (-4.25%)
FLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN Business Wire - Tue Oct 12, 2021

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Flexion Therapeutics, Inc. (NasdaqGM: FLXN)...

FLXN : 9.12 (-0.22%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Flexion Therapeutics, Inc. PR Newswire - Mon Oct 11, 2021

/PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Flexion...

FLXN : 9.12 (-0.22%)
PCRX : 63.59 (+0.87%)

Barchart Exclusives

Stock Market This Week: Five Themes to Watch Barchart - 1 hour ago
With recession fears spiking following a rough series of trades in the equities sector, investors may need to prepare for an unwinding of the post-COVID boom. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CDT
Reserve Your Spot